How does a real-world child psychiatric clinic diagnose and treat attention deficit hyperactivity disorder?
Kumi Yuki, Peter S Jensen, REACH Institute, New York, NY 10018, United States
Jyoti Bhagia, David Mrazek, Division of Child and Adolescent Psychiatry, Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, United States
Peter S Jensen, Division of Child and Adolescent Psychiatry, Department of Psychiatry, University of Arkansas for Medical Sciences, Little Rock, AR 72205, United States
Author contributions: Yuki K designed and performed the research, collected and analyzed the data, and wrote the paper; Bhagia J provided clinical advices for the research; Mrazek D designed the research and provided an initial supervision on the research; Jensen PS supervised the research design and the research process, analyzed the data, and revised the paper.
Institutional review board statement: This naturalistic study is a part of the original study entitled “Pharmacogenetics and the Care of Child and Adolescent Patients”, which was reviewed and approved by the Mayo Clinic Institutional Review Board (IRB).
Informed consent statement: Because this study is a chart review and the research is exempt, a waiver of informed consent was allowed. Study subjects have given authorization for use of their Mayo Clinic electronic medical record for research purposes.
Conflict-of-interest statement: Drs. Yuki and Bhagia have no conflicts to declare. Dr. Jensen has received research funding from NIMH, AHRQ, Marriott Foundation, Mayo Foundation, and REACH Institute (non-profit) and gained book royalties from Civic Research Institute, Guilford, APPI, Oxford, Free Spirit Publishing, and Random House. Dr. Jensen owns a stock in CATCH Services, Inc. Dr. Jensen has received charitable gifts from Shire, Inc.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Kumi Yuki, MD, Research Scientist, REACH Institute, 485 7th Ave #1510, New York, NY 10018, United States. kumiyuki1026@gmail.com
Telephone: +1-507-3161166
Received: May 29, 2015
Peer-review started: June 1, 2015
First decision: September 30, 2015
Revised: December 6, 2015
Accepted: December 18, 2015
Article in press: January 4, 2015
Published online: March 22, 2016
